Anirban Roychowdhury

Also affiliated with Chittaranjan National Cancer Institute, Virginia Commonwealth University Medical Center

Materials ScienceMedicineNeuroscienceEnergy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma”.

Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma

Molecular Medicine(2022)10.1186/s10020-022-00534-0

N/A

0DataRank · unranked

27 citations

Noah B. Herrington, Bandish Kapadia, Anirban Roychowdhury, Nahid Nanaji, Glen E. Kellogg +2 more

PARK2 Regulates eIF4B-Driven Lymphomagenesis

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0729

N/A

0DataRank · unranked

13 citations

Anirban Roychowdhury, Forum Kayastha, Nahid Nanaji, Ronald B. Gartenhaus, Bandish B. Kapadia